Velsera

Velsera’s mission is to be the discovery, evidence-generation, & clinical delivery platform for precision medicine. We help clinical diagnostics and life sciences experts make better decisions about providing the right therapy to the patients at the right time. Velsera was founded in 2023 due to the merger of Seven Bridges, PierianDx & UgenTec. For more information, visit www.velsera.com.